4.7 Review

Fusion genes in gynecologic tumors: the occurrence, molecular mechanism and prospect for therapy

Journal

CELL DEATH & DISEASE
Volume 12, Issue 8, Pages -

Publisher

SPRINGERNATURE
DOI: 10.1038/s41419-021-04065-0

Keywords

-

Categories

Funding

  1. National Natural Scientific Foundation of China [82072854, 81772776]

Ask authors/readers for more resources

Gene fusions are crucial in gynecologic tumors, appearing predominantly in specific cancers and guiding the development of precise treatment strategies. Despite the limited targeted drugs for gynecologic tumors, fusion genes show promise as therapeutic targets.
Gene fusions are thought to be driver mutations in multiple cancers and are an important factor for poor patient prognosis. Most of them appear in specific cancers, thus satisfactory strategies can be developed for the precise treatment of these types of cancer. Currently, there are few targeted drugs to treat gynecologic tumors, and patients with gynecologic cancer often have a poor prognosis because of tumor progression or recurrence. With the application of massively parallel sequencing, a large number of fusion genes have been discovered in gynecologic tumors, and some fusions have been confirmed to be involved in the biological process of tumor progression. To this end, the present article reviews the current research status of all confirmed fusion genes in gynecologic tumors, including their rearrangement mechanism and frequency in ovarian cancer, endometrial cancer, endometrial stromal sarcoma, and other types of uterine tumors. We also describe the mechanisms by which fusion genes are generated and their oncogenic mechanism. Finally, we discuss the prospect of fusion genes as therapeutic targets in gynecologic tumors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available